| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | -40.9% |
| R&D Expense | $30.3M | +83.2% |
| SG&A Expense | $14.0M | -41.3% |
| Operating Income | -$42.9M | -12.7% |
| Income Tax | $0 | — |
| Net Income | -$34.1M | +19.2% |
| EPS (Basic) | -$3.68 | +51.8% |
| EPS (Diluted) | -$3.68 | +51.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.9M | -84.3% |
| Short-term Investments | $11.9M | — |
| Current Assets | $23.8M | -59.6% |
| Total Assets | $44.2M | -47.3% |
| Current Liabilities | $8.0M | -26.2% |
| Total Liabilities | $18.2M | -31.6% |
| Stockholders' Equity | $26.0M | -54.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.3M | -36.5% |
| Capital Expenditures | $337K | +71.1% |
| Investing Cash Flow | -$12.0M | -7733.6% |
| Financing Cash Flow | -$1.2M | -101.8% |
| Free Cash Flow | -$34.6M | -36.8% |